Clinical trial
EPAT: Estrogen in the Prevention of Atherosclerosis Trial
NCT00115024 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00115024 |
|---|---|
| Title | EPAT: Estrogen in the Prevention of Atherosclerosis Trial |
| Official title | Estrogen in the Prevention of Atherosclerosis Trial |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Mead Johnson Nutrition Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Postmenopause |
| Intervention type | Drug |
| Interventions | Micronized 17B-estradiol |
| Enrollment | 222 |
| Start date | Apr 1, 1994 |
| Primary completion | Nov 1, 1998 |
| Completion | Nov 1, 1998 |
| First posted | Jun 21, 2005 |
| Last update posted | Dec 11, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: